Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada

To investigate a potential risk for multiple sclerosis (MS) after vaccination with Arepanrix, the GlaxoSmithKline AS03-adjuvanted influenza A(H1N1)pdm09 vaccine, we used the provincewide immunization registry for Manitoba, Canada, to match 341,347 persons vaccinated during the 2009 pandemic to 485,9...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Emerg Infect Dis
Auteurs principaux: Mahmud, Salaheddin M., Bozat-Emre, Songul, Mostaço-Guidolin, Luiz C., Marrie, Ruth Ann
Format: Artigo
Langue:Inglês
Publié: Centers for Disease Control and Prevention 2018
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6038732/
https://ncbi.nlm.nih.gov/pubmed/29912696
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2407.161783
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires